TITLE

Drug Combo Prevents HIV Infection in Monkeys

PUB. DATE
May 2006
SOURCE
Guide;May2006, Vol. 26 Issue 5, p77
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on a study by Walid Heneine and colleagues at the United States Centers for Disease Control on the effectiveness of Gilead Science's drugs in preventing HIV infections in rhesus monkeys. The drugs are the tenofovir Viread and the emtracitibine Emtriva. The drugs were injected once a day for 14 days, afterwhich they were exposed to a combined monkey-human HIV virus.
ACCESSION #
20791934

 

Related Articles

  • 1 October News.  // Clinical Infectious Diseases;Oct2012, Vol. 55 Issue 7, pi 

    The article offers science news briefs as of October 1, 2012. The U.S. Disease Control and Prevention has recommended for the management of hepatitis B virus (HBV) infected healthcare providers to reduce the risk for transmitting HBV to patients during surgical procedures. Research scientists...

  • CDC's Support for Gilead's HIV Prevention Pill for Women is Reckless Says AHF.  // Biomedical Market Newsletter;8/28/2012, Vol. 21, p1 

    The article focuses on the new guidelines issued by the U.S. Centers for Disease Control and Prevention (CDC) for the expansion of the usage of drugs from Gilead Sciences Inc. It informs that these guidelines are being opposed by AIDS Healthcare Foundation (AHF) due to unavailability of...

  • CDC's Support for Gilead's HIV Prevention Pill for Women is Reckless Says AHF.  // Biomedical Market Newsletter;8/15/2012, Vol. 21, p1 

    The article offers information that AIDS Healthcare Foundation (AHF) commented on the new guidance from the U.S. Centers for Disease Control and Prevention (CDC) for the expansion of the use of AIDS treatment drug Truvada from Gilead Sciences Inc. as pre-exposure prophylaxis (PrEP) from gay and...

  • (RESOURCES) CDC Looking to Control Drug Resistance Infections.  // Community Health Funding Week;3/18/2011, p21 

    The article reports that the Centers for Disease Control and Prevention (CDC) in the U.S. has requested comments on its draft, "A Public Health Action Plan to Combat Antimicrobial Resistance."

  • CDC educates on problem of antimicrobial resistance.  // Nation's Health;Apr2002, Vol. 32 Issue 3, p4 

    Reports on the launching of a campaign by the U.S. Centers for Disease Control and Prevention to educate clinicians on ways to combat antimicrobial resistance. Recommendations of the campaign to physicians; Result of a poll on awareness of adults regarding antibiotic resistance; Factors leading...

  • CDC targets hospital infections. Evans, Melanie // Modern Healthcare;2/1/2010, Vol. 40 Issue 5, p17 

    The article offers information on a proposal by the U.S. Centers for Disease Control and Prevention to conduct two surveys regarding healthcare-acquired infections and the anti-microbial drugs used to prevent such infections. According to the Federal Register, the proposal states that 30...

  • CDC Changes Treatment Guidelines for Gonorrhea. Armstrong, Carrie // American Family Physician;6/1/2007, Vol. 75 Issue 11, p1715 

    The article focuses on the revised guidelines for the treatment of gonorrhea issued by the U.S. Centers for Disease Control and Prevention (CDC). The rules indicate that fluoroquinolone antibiotics are no longer recommended as medication for gonococcal infections and pelvic inflammatory disease....

  • Antibiotics are not candy. Zammett, Erin // Redbook;Jun2012, Vol. 218 Issue 6, p149 

    The article discusses the harmful effects of taking excessive antibiotics. Lauri Hicks, a medical epidemiologist and the director of the "Get Smart: Know When Antibiotics Work" campaign for the U.S. Centers for Disease Control and Prevention (CDC), says people have a habit of skipping doses and...

  • Antimicrobial Prescribing in the United States: Good News, Bad News. Besser, Richard E. // Annals of Internal Medicine;4/1/2003, Vol. 138 Issue 7, p605 

    Editorial. Reports on doctors' prescription of anti-infective agents in the United States. Promotion of antimicrobial resistance owing to appropriate or inappropriate use of anti-infective agents; Decrease in prescription following the U.S. Centers for Disease Control and Prevention's...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics